KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Cost of Revenue (2016 - 2025)

Amgen (AMGN) has 17 years of Cost of Revenue data on record, last reported at $3.0 billion in Q4 2025.

  • For Q4 2025, Cost of Revenue fell 76.51% year-over-year to $3.0 billion; the TTM value through Dec 2025 reached $12.0 billion, down 46.3%, while the annual FY2025 figure was $12.0 billion, 6.39% down from the prior year.
  • Cost of Revenue reached $3.0 billion in Q4 2025 per AMGN's latest filing, down from $8.2 billion in the prior quarter.
  • Across five years, Cost of Revenue topped out at $12.7 billion in Q4 2024 and bottomed at -$4.5 billion in Q4 2021.
  • Average Cost of Revenue over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2021.
  • The widest YoY moves for Cost of Revenue: up 160800.0% in 2021, down 16922.22% in 2021.
  • A 5-year view of Cost of Revenue shows it stood at -$4.5 billion in 2021, then grew by 8.5% to -$4.2 billion in 2022, then dropped by 7.31% to -$4.5 billion in 2023, then surged by 384.1% to $12.7 billion in 2024, then crashed by 76.51% to $3.0 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $3.0 billion in Q4 2025, $8.2 billion in Q3 2025, and -$2.1 billion in Q2 2025.